Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiaoqiong Gu has a total of 265 co-authors. Here are the top co-authors by number of shared publications:

  • Lei Pi

    Guangzhou Women and Children's Medical Center Guangzhou Medical University Guangzhou China

    36 shared publications
  • Yufen Xu

    Guangzhou Women and Children's Medical Center Guangzhou Medical University Guangzhou China

    36 shared publications
  • Di Che

    Department of Clinical Biological Resource Bank Guangzhou Women and Children's Medical Center Guangzhou Medical University Guangzhou People's Republic of China

    30 shared publications
  • Huazhong Zhou

    Guangzhou Women and Children's Medical Center Guangzhou Medical University Guangzhou China

    27 shared publications
  • Lanyan Fu

    Guangzhou Women and Children's Medical Center Guangzhou Medical University Guangzhou China

    25 shared publications
  • Di Che

    Department of Clinical Biological Resource Bank, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510623, China

    18 shared publications

Latest Publications

  • Open Access

    scGEN: Leveraging an Adaptive Weighting Strategy for Challenging Cell Clustering in Single‐Cell RNA‐seq

    by Fang Huang, Dayu Hu, Yaqi Dai, Aoyi Geng, Renxiang Guan, Hao Quan, Brett A. McGregor, Zhihan Wang, Nadeem Khan, Hongsheng Zhang, et al.

    Recent advancements in single‐cell RNA sequencing (scRNA‐seq) have greatly enhanced our ability to dissect cellular heterogeneity. However, unsupervised clustering often struggles to identify transitional or developmental boundary cells, as existing methods rely on highly variable genes without considering expression levels, thereby overlooking subtle but crucial signals. To address this challenge, we developed a single‐cell gene‐aware embedded network (scGEN), which captures complex intercellular relationships. scGEN employs adaptive feature weighting and iterative fine‐tuning to prioritize ambiguous or transitional cells with overlapping transcriptional profiles. Evaluation across eight distinct scRNA‐seq datasets demonstrated that scGEN consistently outperformed nine leading clustering approaches. Additionally, scGEN generated refined assignments for approximately 10% of cells with ambiguous transcriptional profiles and revealed biologically meaningful differences, providing a more detailed view of cellular heterogeneity in the human fetal pituitary. Cell–cell communication analysis identified developmental signaling networks associated with the refined annotations, including a putative Pre.Gonado‐like population detected at 7 weeks with prominent involvement in BMP, NOTCH, and extracellular matrix remodeling pathways. Furthermore, histological analysis of 6–8‐week embryos provided orthogonal tissue‐level support for early gonadotrope‐lineage states and SOX2–GATA2–NR5A1 bridging populations. Together, these results highlight scGEN's ability to enhance cell‐type assignments and detect subtle biological differences.

  • Open Access

    Comprehensive spatial profiling reveals transitional microbiome dynamics and microbial heterogeneity in pediatric adenoid hypertrophy

    by Kaining Chen, Xin Wan, Wenli Guo, Hongyan Yu, Yuantao Tong, Huiwen Ke, Junjie Fang, Xilian Luo, Di Che, Chao Hou, et al.

    This study characterizes the upper respiratory microbiome in 276 children (101 Adenoid hypertrophy (AH) 119 Adenotonsillar hypertrophy (ATH), 11 Tonsil hypertrophy (TH), and 45 healthy controls by analyzing 1149 samples across five distinct niches: nasopharyngeal swabs (NS), adenoid swab (AS), and tonsil swabs (TS), plus adenoid tissues (AT) and tonsil tissues (TT). Utilizing a workflow of 16S rRNA sequencing, qPCR, and metagenomics, we identified significant spatial heterogeneity and niche-specific dominance, such as Staphylococcus in the nasopharynx and Streptococcus on mucosal surfaces. AT exhibited a transitional microbiome with intermediate composition and unique Ralstonia enrichment. Machine learning models demonstrate that AT microbial profiles (area under curve, AUC = 0.752) offer superior predictive power for AH severity compared to surface swabs. SHAP analysis identified key contributing genera, such as Roseburia and Flavobacterium, as primary drivers of these predictive outcomes. These findings highlight how tissue-infiltrating microbial dynamics drive chronic inflammation and pediatric hypertrophy.

  • Open Access

    Characterization of the oral microbiota of Kawasaki disease patients by metagenomic analysis: A pilot study

    by Yuantao Tong, Yuxin Chen, Yifan Dong, Kaining Chen, Juhua Yang, Xuefan Dong, Xin Wan, Ziheng Luo, Junjie Fang, Yunfeng Liu, et al.

  • Risk factors and long-term follow-up in acute Kawasaki disease patients with medium or large coronary artery aneurysms

    by Wei Li, Yuantao Tong, Xiqiao Xue, Lu Su, Yu-Jian Wu, Xiaofei Xie, Yanfei Wang, Mingsheng Tang, Han Zhang, Lin Hu, et al.

    Paediatric Rheumatology; Authors: W. Li, Y. Tong, X. Xue, L. Su, Y.-J. Wu, X. Xie, Y. Wang, M. Tang, H. Zhang, L. Hu, F. Wang, X. Gu, Z. Wang

  • Open Access

    T-cadherin deprivation in endothelial cells promotes vascular injury in Kawasaki disease through SOD2/ROS/NLRP3 pathway-mediated pyroptosis

    by Yueling Lin, Fei Wang, Xilian Luo, Xiangna Yang, Wan Yang, Zhaojin Lu, Zhouping Wang, Huazhong Zhou, Meiying Ruan, Kaining Chen, et al.

    Kawasaki disease (KD) is an acute febrile systemic vasculitis associated with the development of coronary artery lesion and coronary artery aneurysm. This condition is characterized by sustained vascular inflammation and endothelial dysfunction, in which pyroptosis serves as a pivotal driver of inflammatory response. However, the molecular mechanisms linking pyroptosis to endothelium injury and KD pathogenesis remain poorly understood. Analysis of public datasets revealed a marked decrease in T-cadherin (T-cad, CDH13) expression in cardiac tissues from KD patients and KD model mice compared to controls. In vitro and in vivo experiments revealed the reduced T-cad expression in both the treated human umbilical vein endothelial cells (HUVECs) and the abdominal aorta of Lactobacillus casei cell wall extract-induced KD mice. RNA sequencing analysis of HUVECs with siRNA-mediated T-cad knockdown showed significant enrichment of genes involved in pro-inflammatory cascades and pyroptosis-associated pathways. Western blot analysis further validated the upregulation of pyroptosis-associated proteins, including NLRP3, caspase-1, GSDMD, IL-1β, and IL-18, in the T-cad knockdown group compared to controls. These findings were supported by functional assays demonstrating the increased lactate dehydrogenase release, higher TUNEL-positive cells, and elevated reactive oxygen species (ROS) levels in the T-cad knockdown group. Collectively, our results indicate that inflammatory stimuli downregulate T-cad expression in endothelial cells, subsequently reducing superoxide dismutase 2 (SOD2) expression and its enzymatic activity. This leads to ROS accumulation, which activates the NLRP3 inflammasome and initiates pyroptosis. Thus, T-cad deficiency induces pyroptosis in HUVECs via the activation of the SOD2/ROS/NLRP3 pathway. These findings highlight the pivotal role of T-cad deprivation-mediated endothelial cell pyroptosis in the initiation and progression of KD, providing novel insights into its pathophysiology and potential therapeutic targets.


  • Open Access

    LINC00461 SNPs rs933647 and rs201864123 modify the risk of adenoid hypertrophy susceptibility for children in South China

    by Chao Hou, Xilian Luo, Xin Wan, Kaining Chen, Zhongren Xian, Kaixiong Xu, Yingjia Zeng, Chenlu Wang, Wan Yang, Zilin Zheng, et al.

    Background: Adenoidal hypertrophy (AH) is commonly observed in childhood and closely linked to obstructive sleep apnea (OSA). Despite the high prevalence of AH, its pathophysiological mechanisms remain incompletely understood. We attempt to explore this issue from a genetic perspective. Elevated levels of LINC00461 have been identified in OSA tissues. We aimed to explore the relationship between susceptibility to adenoid hypertrophy and LINC00461 gene polymorphisms.Methods: We genotyped the LINC00461 single nucleotide polymorphisms (SNPs) rs933647 and rs201864123 in 546 AH patients and 574 healthy controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to assess the association between the SNPs and AH risk. The SIPI (Susceptible-Infected-Protected-Infected) method was utilized to analyze SNP-SNP interactions between rs933647 and rs201864123.Results: Our study found that the rs933647 GA polymorphism was associated with an increased risk of AH. Similarly, the T allele of SNP rs201864123 increased AH risk in southern Chinese children. Furthermore, SIPI analysis demonstrated an interaction between these SNPs associated with adenoid hypertrophy risk.Conclusion: The LINC00461 rs933647 GA genotype and rs201864123 T variant may contribute to the susceptibility of AH in the child population of China.


  • Open Access

    Platelet–Monocyte Aggregate Instigates Inflammation and Vasculopathy in Kawasaki Disease

    by Yuan Zhang, Cuiping Jia, Manli Guo, Qian Chen, Ying Wen, Ting Wang, Yinyin Xie, Xuejiao Fan, Jingwen Gao, Timur O. Yarovinsky, et al.

    Kawasaki disease (KD) is a severe acute febrile illness and systemic vasculitis that causes coronary artery aneurysms in young children. Platelet hyperreactivity and an aberrant immune response are key indicators of KD; however, the mechanism by which hyperactive platelets contribute to inflammation and vasculopathy in KD remains unclear. A cytokine‐mediated positive feedback loop between KD platelets and monocytes is identified. KD platelet–monocyte aggregates (MPAs) are mediated by an initial interaction of P‐selectin (cluster of differentiation 62P, CD62p) and its glycoprotein ligand 1 (PSGL‐1). This is followed by a coordinated interaction of platelet glycoprotein (GP)Ibα with monocyte CD11b. Monocyte‐activated platelets initiate transforming growth factor (TGF)β1 release, which results in nuclear localization of nuclear factor kappaB in monocytes, therefore, driving the phenotypic conversion of classical monocytes (CD14+CD16−) into proinflammatory monocytes (CD14+CD16+). The platelet‐activated monocytes release interleukin‐1 and tissue necrotic factor‐α, which promote further platelet activation. KD‐induced inflammation and vasculopathy are prevented by inhibiting the components of this positive feedback loop. Notably, mice deficient in platelet TGFβ1 show less MPA and CD14+CD16+ monocytes, along with reduced inflammation and vasculopathy. These findings reveal that platelet–monocyte interactive proteins (CD62p/PSGL‐1 and (GP)Ibα/CD11b) and cytokine mediators (platelet TGFβ1) are potential biomarkers and therapeutic targets for KD vasculopathy.


  • Open Access

    Susceptibility of TSPAN5 polymorphisms to Kawasaki disease and immunoglobulin therapy resistance in southern Chinese children

    by Kaining Chen, Xilian Luo, Huazhong Zhou, Lanyan Fu, Zhaojin Lu, Chenlu Wang, Yueling Lin, Hongyan Yu, Yufen Xu, Lei Pi, et al.


  • Open Access

    LincRNA-NR_024015 rs8506 TT genotype contributes to the risk of sepsis in a southern Chinese child population

    by Xiaoqiong Gu, Jinqing Li, Hehong Li, Bing Wei, Di Che, Yufen Xu, Lei Pi, Lanyan Fu, Huazhong Zhou

    Sepsis is a life-threatening heterogeneous syndrome due to a dysregulated immune response to infection. Studies have shown that genetic polymorphisms might have impact on the risk of sepsis. LincRNA-NR_024015, also known as testis development related 1(TDRG1), is a newly identified long non-coding RNA (lncRNA). It has been found to participate in vascular endothelial growth factor (VEGF) signaling in human diseases, but its relevance in the development of sepsis is still unclear. In the present study, we genotyped lncRNA TDRG1 rs8506 polymorphism in 474 patients and 678 healthy controls recruited from a southern Chinese child population using Taqman methodology. Overall, a significant association was found between rs8506 polymorphism and the risk of sepsis disease (TT vs. CC/CT: adjusted OR = 1.751, 95%CI = 1.024–2.993, P = 0.0406). In the stratified analysis, the results suggested that the carriers of TT genotypes had a significantly increased sepsis risk among the children aged 12–60 months, females, early-stage sepsis and survivors (TT vs. CC/CT: ORage = 2.413; ORfemale = 2.868; ORsepsis = 2.533; ORsurvivor = 1.822; adjusted for age and gender, P < 0.05, respectively). Our study indicated that lncRNA TDRG1 rs8506 TT genotype might contribute to the risk of sepsis in a southern Chinese child population. Future research is required to elucidate the possible immunoregulatory mechanisms of this association.